Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan.

Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan. Abstract Text:

Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan. Publishing Authors By Initials

For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

PUBMED ID PMID:

MEDLINE DATE:

Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan. Journal Published:

PUBLICATION TYPE: Review

Journal: Blood pressure. Supplement

VOLUME: 2

Page Numbers: 5-15

Journal Abbreviation:

ISSN: 0803-8023

DAY: 26

MONTH: Dec

YEAR: 2003

Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan. Information

Number of References: 81

LANGUAGE: eng

NlmUniqueID: 9300787

Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan. Keywords Mesh Terms:

KEYWORDS: Treatment Outcome

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan. Information

Substance Name: candesartan

Registry Number: 139481-59-7

Grant and Affiliation Information for Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan.

AFFILIATION: From Istituto di Medicina Cardiovascolare and Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Università and Ospedale Maggiore IRCCS and Istituto Auxologico, Ospedale S Luca, Milano, Italy. dhipertensione@libero.it

Country: Norway

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Blood Press Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan Related Publications

• Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
• Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE).
• Cardiac, renal and vascular complications in the diabetic patient.
• Cardiovascular consequences of hypertension: therapeutic effects on organ damage and on cardiovascular events.
• Cardiovascular effects of afferent renal nerve stimulation.
• Carotid baroreceptor reflex in normotensive and hypertensive subjects.
• Characteristics of an ideal antihypertensive therapy for elderly hypertensives.
• Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage.
• Comparative measurements of immunoreactive renin, plasma renin activity and angiotensin II in human plasma.
• Differences in reflex control of arterial pressure and renin release during head-up tilting in the cat.
• Editing a scientific journal: problems and challenges.
• Evaluation of a new non-invasive semiautomatic blood pressure monitoring device.
• Factors influencing the carotid baroreceptor response to pressure changes in a neck chamber.
• Hemodynamic and neural effects of urapidil and prazosin in essential hypertensives.
• Interplay of sino-aortic reflexes and haemodynamic changes during natural sleep in the cat.
• Introduction.
• Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan.
• Mechanisms of blood pressure variability in man.
• Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study.
• Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atheroscelerosis (ELSA).
• Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.
• Renin release and renal vasomotor changes during stimulation of the brain stem in the cat.
• Role of the renal nerves in renin release during suprarenal aortic stenosis in cats.
• Target blood pressure in elderly hypertensive patients: how low should you go?
• The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence.
• The sympathetic nervous system in human hypertension.
• Time course of the changes in active and cryoactivatable renin in response to acute stimuli before and after diuretic therapy in man.
• Urapidil in hypercholesterolemic hypertensive patients.
• Value of echocardiographic and ambulatory blood pressure monitoring in hypertension.
• [Not Available.]